• Fr!ska is an innovative food supplement that combines probiotics, botanicals, and Enzymes.
  • KYBORA identified the acquisition opportunity, presented it to Megalabs, and lead the process that resulted in the acquisition.
  • The agreement demonstrates KYBORA’s ability to drive cross borders merger and acquisition transactions in the US OTC space and deliver value added services to global clients.
  • To learn more about our M&A services, please click here.

About the author.


20 years of experience in international business development in the pharmaceutical industry. Head of commercial operations and business development for Bristol-Myers Squibb in 16 Latin American countries. Global management consultant. Speaks French and Spanish fluently. Completed nine transactions in global markets in the past three years.

No Comments. Leave a comment  

Leave a Reply

Your email address will not be published. Required fields are marked *